CRISPR based therapeutics: a new paradigm in cancer precision medicine

BACKGROUND: Clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated protein (Cas) systems are the latest addition to the plethora of gene-editing tools. These systems have been repurposed from their natural counterparts by means of both guide RNA and Cas nuclease engineer...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Sumit, Bano, Shehnaz, Kapse, Prachi, Kundu, Gopal C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953071/
https://www.ncbi.nlm.nih.gov/pubmed/35337340
http://dx.doi.org/10.1186/s12943-022-01552-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953071/
https://www.ncbi.nlm.nih.gov/pubmed/35337340
http://dx.doi.org/10.1186/s12943-022-01552-6

Ejemplares similares